{"disease":{"id":"covid-19-prevention-in-individuals-6-months-through-4-years-of-age-with-a-third-dose-administered-at-least-2-months-after-the-second-dose-and-a-fourth-dose-administered-at-least-2-months-after-the-third-dose-and-a-fifth-dose-administered-at-least-2-months-after-the-fourth-dose-and-a-sixth-dose-administered-at-least-2-months-after-the-fifth-dose.md","name":"covid 19 prevention in individuals 6 months through 4 years of age with a third dose administered at least 2 months after the second dose and a fourth dose administered at least 2 months after the third dose and a fifth dose administered at least 2 months after the fourth dose and a sixth dose administered at least 2 months after the fifth dose.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}